Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.
For many years, the gold standard cancer grading and staging had focused on the characteristics of the cancer cells and often disregarded the non-tumoral cell compartments. The expansion of research on the tumor immune microenvironment, the successes and dissemination of immunotherapies to treat can...
| Publicado en: | Virchows Archiv: European Journal of Pathology Vol. 474; no. 4; pp. 463 - 475 |
|---|---|
| Autores principales: | , , , |
| Formato: | research Journal Article |
| Publicado: |
Springer Nature
Apr2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |